Patent · US Active

Anti-TIGIT antigen-binding proteins and methods of uses thereof

US11590224B2 · kind B2 · utility

0Cited by

7References

8Claims

0Family size

Assignee

Potenza Therapeutics, Inc. · US

Inventors

Daniel Hicklin · Montclair, US
William Winston · Marlborough, US
Cynthia S. Dugan · Belmont, US
Nels P. Nielson · Cambridge, US

Key dates

Filing date	Oct 22, 2019
Grant date	Feb 28, 2023
Priority date	—
Expiry date	Feb 10, 2041

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are antigen-binding proteins (ABPs) that selectively bind to TIGIT and its isoforms and homologs, and compositions comprising the ABPs. Also provided are methods of using the ABPs, such as therapeutic and diagnostic methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.